Virtus Investment Trust Files Summary Prospectus for Fund
Virtus Investment Trust has filed a summary prospectus for its Virtus NFJ Small-Cap Value Fund, detailing investment objectives and fees.
Virtus Investment Trust Files Summary Prospectus for Fund
Virtus Investment Trust files a summary prospectus for the Virtus Silvant Focused Growth Fund, detailing investment objectives and fees.
Forum Funds files registration for new Pragmatic ETF
Forum Funds has filed a registration statement for its new Pragmatic ETF, aiming to enhance its investment offerings and compete in the ETF market.
Virtus Investment Trust updates prospectus for fund
Virtus Investment Trust files a new prospectus for its Emerging Markets Opportunities Fund, detailing fees and investment objectives.
Virtus Investment Trust files summary prospectus for fund
Virtus Investment Trust has filed a new summary prospectus for its Income & Growth Fund, focusing on investment goals and fees.
Benitec Biopharma announces positive BB-301 trial results
Benitec Biopharma Inc. shares positive interim results for BB-301, indicating progress in its clinical trials and potential industry impact.
FuelCell Energy appoints Peter Hopper to board of directors
FuelCell Energy Inc. appoints Peter Hopper to its board, enhancing leadership as the company navigates the Electrical Industrial Apparatus sector.
Palvella Therapeutics Secures FDA Priority Review for QTORIN™
Palvella Therapeutics announces FDA acceptance of its New Drug Application for QTORIN™, a significant milestone in the pharmaceutical preparations sector.
LORD ABBETT TRUST I Reports Strong Financial Activity
LORD ABBETT TRUST I's latest filing reveals strong net sales and financial metrics, indicating growth in the investment management sector.
LORD ABBETT Reports Significant Redemptions in Latest Filing
LORD ABBETT DEVELOPING GROWTH FUND reports significant redemptions in its latest SEC filing, indicating challenges in attracting new investments.
Genprex to Present Research at GSA Annual Scientific Meeting
Genprex, Inc. will showcase its research on TUSC2 and REQORSA at the GSA Annual Scientific Meeting, indicating potential therapeutic advancements.
Sweet Julie Spellman acquires 12,200 shares of Accenture
Sweet Julie Spellman has acquired 12,200 shares of Accenture plc, reinforcing her commitment as Chair and CEO amid a competitive business services sector.
Putnam ETF Trust Files Certified Shareholder Report
Putnam ETF Trust files its certified shareholder report, providing insights into performance and management for its investment products.
UBS Group AG releases third quarter 2026 financial results
UBS Group AG has reported its third quarter 2026 financial results, showcasing key metrics and insights into the bank's performance.
Banco Santander Reports Financial Results for 2026 Q3
Banco Santander, S.A. releases its financial results for January to September 2026, showcasing key performance metrics and insights.
Nationwide Fund Advisors reveals Q3 2026 investment portfolio
Nationwide Fund Advisors discloses its investment portfolio in the latest 13F-HR filing, showcasing significant asset allocations as of September 30, 2026.
UBS Group AG discloses Q3 2026 capital instruments details
UBS Group AG reveals its consolidated capital instruments and TLAC-eligible senior unsecured debt information for Q3 2026, emphasizing financial stability.
UBS AG Reports Third Quarter Results for 2026
UBS AG has released its third-quarter report for 2026, detailing financial performance and strategic updates in the national commercial banks sector.
Cellectis unveils promising data for APOC3-targeting therapy
Cellectis S.A. presents preclinical data for .HEAL-101, a gene therapy targeting APOC3, at ESGCT 2026, signaling potential advancements in genetic medicines.
AUNA S.A. Announces Corporate Reorganization in Mexico
AUNA S.A. has reorganized its corporate structure, transferring its hospital business to a new subsidiary to enhance operational efficiency.